---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-038004"
form_type: "8-K"
ticker: null
cik: "0001779020"
company_name: "Danimer Scientific, Inc."
filed_at: "2024-03-28T23:59:59+00:00"
generated_at: "2026-06-04T06:22:25.153289+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Danimer reports FY2023 revenue down 12% to $46.7M; guides FY2024 Adj. EBITDA improvement

## Summary
- Q4 revenue $10.9M (-29% YoY); full-year revenue $46.7M vs $53.2M.
- Full-year Adj. EBITDA $(39.0)M vs $(45.0)M in 2022; Q4 Adj. EBITDA $(10.7)M.
- FY2024 Adj. EBITDA guidance $(22)-(32)M; CapEx $8-10M; expects accelerating H2 growth.
- Unrestricted cash $59.2M at Dec 31, 2023; March 2024 equity raise added >$13M.
- PHA sales grew 6% YoY; PLA sales declined $6.1M due to Ukraine conflict.

## SEC filing metadata
- accession: 0000950170-24-038004
- form_type: 8-K
- cik: 0001779020
- company_name: Danimer Scientific, Inc.
- filed_at: 2024-03-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779020/000095017024038004/0000950170-24-038004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779020/000095017024038004/dnmr-20240328.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-038004
- JSON: https://secwatch.observer/filing/0000950170-24-038004.json
- Plain text: https://secwatch.observer/filing/0000950170-24-038004.txt

## Key facts
- Earnings Releases
  Danimer Scientific, Inc. updated its fourth quarter and full year ended December 31, 2023 guidance (reaffirmed).
  - Period: fourth quarter and full year ended December 31, 2023
  - Guidance: reaffirmed
  - Result: reported results
  source text: On March 28, 2024, Danimer Scientific, Inc. (“Danimer”) issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1779020/000095017024038004/0000950170-24-038004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.